XML 46 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Loss before income tax - Summary of Loss Before Income Tax (Details) - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue    
Commercialization revenue $ 3,388 $ 3,422
Total Revenue 3,388 3,422
Clinical trial and research & development (2,045) (4,067)
Manufacturing production & development (5,484) (11,717)
Employee benefits    
Salaries and employee benefits (10,096) (9,842)
Defined contribution superannuation expenses (199) (186)
Equity settled share-based payment transactions (2,195) (1,757)
Total Employee benefits (12,490) (11,785)
Depreciation and amortization of non-current assets    
Plant and equipment depreciation (281) (565)
Right of use asset depreciation (1,420) (875)
Intellectual property amortization (742) (750)
Total Depreciation and amortization of non-current assets (2,443) (2,190)
Other Management & administration expenses    
Overheads & administration (4,594) (5,187)
Consultancy (1,285) (1,967)
Legal and other professional fees (1,124) (1,053)
Intellectual property expenses (excluding the amount amortized above) (1,410) (1,505)
Total Other Management & administration expenses (8,413) (9,712)
Fair value remeasurement of contingent consideration    
Remeasurement of contingent consideration (337) 5,989
Total Fair value remeasurement of contingent consideration (337) 5,989
Fair value remeasurement of warrant liability    
Remeasurement of warrant liability 4,434 (712)
Total Fair value remeasurement of warrant liability 4,434 (712)
Other operating income and expenses    
Interest revenue 903 214
Foreign exchange gains/(losses) 165 (253)
Total Other operating income and expenses 1,068 (39)
Finance (costs)/gains    
Remeasurement of borrowing arrangements (120) (1,230)
Interest expense (10,199) (9,455)
Total Finance costs (10,319) (10,685)
Loss before income tax $ (32,641) $ (41,496)